Company intelligence / Profile preview

AI Hub Singapore

Singapore, Singaporeaihub.sg ↗

Ownership: Private
Development stage: Other

Overview

AI Hub Singapore offers commercialized artificial intelligence platforms that support business innovation across sectors. In healthcare specifically, its HealthASSIST product delivers diagnostic support for X-rays and disease classification using machine learning models. No clinical trial results are reported as the company does not develop therapeutics.

Therapeutic areas: PulmonologyEndocrinologyRheumatologyInfectious Diseases
Modalities: Artificial intelligence softwaremachine learninggenerative AI
Industry: Digital Health Medical Devices

Partnerships

Notable collaborations with academic institutions such as National University of Singapore for training/internships in the broader context of the local ecosystem. No specific pharma or biotech partnerships listed.

Beyond the preview

Go deeper on AI Hub Singapore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AI Hub Singapore.

Explore the full profile